Explore a selection of recent articles and posters our company and collaborators have generated. We will continue to be active contributors to the scientific community, further advancing the delivery of precision medicine and improved patient outcomes.
Diagnostic Accuracy of a Host Gene Expression Signature That Discriminates Clinical Severe Sepsis Syndrome and Infection-Negative Systemic Inflammation Among Critically Ill Children
Zimmerman et al. 2017, Critical Care Medicine
A pilot study of a novel molecular host response assay to diagnose infection in patients after high-risk gastro-intestinal surgery
Verboom et al. 2019, Journal of Critical Care
Septicyte® RAPID in sepsis cases with malignancy or treated with antineoplastics/immunosuppressants
Davis et al. 2021, SCCM 2021 Poster
In-silico performance of a rapid sepsis test in patients with candidemia
Sengers et al. 2020, AMP Poster
Comparison of a cartridge-based host gene expression test to a manual method for use in the diagnosis of sepsis
Cermelli et al. 2020, AMP Poster
Comparison of lactate, procalcitonin and a gene signature assay alone or in combination to differentiate sepsis from infection negative systematic inflammation in ICU patients
You are about to exit for another Biocartis country or region specific section.
Please be aware that the section you have requested is intended for the residents of a particular country or countries.
As a result, the section may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Do you wish to continue and proceed to the US section?
